JOHN SIMMONS: Open Payments
NPI 1942452123 · GENEVA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$184 in 10 payments from 6 companies in 2025. Trend: 2023 $660 · 2024 $373 · 2025 $184
Food & beverage: $165Education: $19
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $76 |
| Exact Sciences Corporation | 2 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
| Averitas Pharma Inc. | 1 | $16 |
Products named: CAPLYTA, Cologuard Collection Kit, GEMTESA, JARDIANCE, VRAYLAR, QUTENZA.
Industry payments across AL — which companies pay providers there.
